168 related articles for article (PubMed ID: 33476180)
21. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
22. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
23. The MEK1 scaffolding protein MP1 regulates cell spreading by integrating PAK1 and Rho signals.
Pullikuth A; McKinnon E; Schaeffer HJ; Catling AD
Mol Cell Biol; 2005 Jun; 25(12):5119-33. PubMed ID: 15923628
[TBL] [Abstract][Full Text] [Related]
24. In vivo severity ranking of Ras pathway mutations associated with developmental disorders.
Jindal GA; Goyal Y; Yamaya K; Futran AS; Kountouridis I; Balgobin CA; Schüpbach T; Burdine RD; Shvartsman SY
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):510-515. PubMed ID: 28049852
[TBL] [Abstract][Full Text] [Related]
25. Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells.
Pike T; Widberg C; Goodall A; Payne E; Giles N; Hancock J; Gabrielli B
Cell Signal; 2013 Jun; 25(6):1423-8. PubMed ID: 23524336
[TBL] [Abstract][Full Text] [Related]
26. An Activating Mutation in ERK Causes Hyperplastic Tumors in a
Kushnir T; Bar-Cohen S; Mooshayef N; Lange R; Bar-Sinai A; Rozen H; Salzberg A; Engelberg D; Paroush Z
Genetics; 2020 Jan; 214(1):109-120. PubMed ID: 31740452
[TBL] [Abstract][Full Text] [Related]
27. Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.
Shen CP; Tsimberg Y; Salvadore C; Meller E
BMC Neurosci; 2004 Sep; 5():36. PubMed ID: 15380027
[TBL] [Abstract][Full Text] [Related]
28. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
29. Disruption of brain MEK-ERK sequential phosphorylation and activation during midazolam-induced hypnosis in mice: Roles of GABA
Álvaro-Bartolomé M; Salort G; García-Sevilla JA
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():84-93. PubMed ID: 28111292
[TBL] [Abstract][Full Text] [Related]
30. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
[TBL] [Abstract][Full Text] [Related]
31. BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity.
Emery CM; Monaco KA; Wang P; Balak M; Freeman A; Meltzer J; Delach SM; Rakiec D; Ruddy DA; Korn JM; Haling J; Acker MG; Caponigro G
Mol Cancer Res; 2017 Oct; 15(10):1431-1444. PubMed ID: 28655712
[TBL] [Abstract][Full Text] [Related]
32. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway.
Kang NJ; Lee KW; Rogozin EA; Cho YY; Heo YS; Bode AM; Lee HJ; Dong Z
J Biol Chem; 2007 Nov; 282(45):32856-66. PubMed ID: 17724030
[TBL] [Abstract][Full Text] [Related]
33. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
34. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
[TBL] [Abstract][Full Text] [Related]
35. MEK1/2 dual-specificity protein kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
[TBL] [Abstract][Full Text] [Related]
36. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation.
Nyunoya T; Monick MM; Powers LS; Yarovinsky TO; Hunninghake GW
J Biol Chem; 2005 Jul; 280(28):26295-302. PubMed ID: 15901735
[TBL] [Abstract][Full Text] [Related]
37. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
38. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.
Senawong T; Phuchareon J; Ohara O; McCormick F; Rauen KA; Tetsu O
Hum Mol Genet; 2008 Feb; 17(3):419-30. PubMed ID: 17981815
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of dual-specificity phosphatases is involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp72.
Yaglom J; O'Callaghan-Sunol C; Gabai V; Sherman MY
Mol Cell Biol; 2003 Jun; 23(11):3813-24. PubMed ID: 12748284
[TBL] [Abstract][Full Text] [Related]
40. Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion.
Eblen ST; Slack-Davis JK; Tarcsafalvi A; Parsons JT; Weber MJ; Catling AD
Mol Cell Biol; 2004 Mar; 24(6):2308-17. PubMed ID: 14993270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
